French Servier to Acquire US Edgewise Muscular Dystrophy Business for $2.65 Billion, Strengthening Rare Neurological Disease Pipeline
French pharmaceutical group Servier announced on June 1 that it has reached an agreement with US bio...
Belgium's IBA Launches Cyclotron Dedicated to At-211, Bridging the Scale-Up Gap in Targeted Alpha Therapy Supply Chain
Belgian particle accelerator technology company Ion Beam Applications S.A. (IBA) recently launched t...
Shanghe Launches Pharmaceutical Online Inspection Solution with 50mg Accuracy
Shanghe Automation Instrument Equipment (Shanghai) Co., Ltd. has launched a series of online inspect...
Mexico Secures 21 Billion Pesos in Healthcare Investment, Expanding Drug Production and Medical Supply Chains
The Mexican federal government recently announced that pharmaceutical and healthcare companies have ...
France's Abivax Announces Positive Phase III Trial Results for Obefazimod in UC
Abivax announced positive topline results from the Phase 3 ABTECT maintenance trial of its oral miR-...
China's National Health Commission: Strengthening comprehensive child health services during the "15th Five-Year Plan" period
Xie Yang, spokesperson for the National Health Commission and Director of the Department of Publicit...
Swiss Biotech Startup hephaistos.bio Receives CHF 150,000 from Venture Kick
Swiss biotech startup hephaistos.bio has received CHF 150,000 in funding from Venture Kick, aiming t...
China's self-developed first-in-class drugs entering clinical trials have increased 12-fold in a decade
The number of China's self-developed First-in-Class (FIC) drug candidates entering clinical trials g...
Newcastle University Develops ReJI Bioprinted 3D Tissue Models for Drug Screening
Dr. Priscila Melo, a Lecturer in Bioengineering at Newcastle University and co-founder of JetBio, is...
Australia's first $96 million RNA manufacturing facility opens in New South Wales
Australia's first dedicated RNA research and manufacturing facility, designed by HDR, has officially...
South Korea Launches First Industrial-Scale mRNA Vaccine Production Platform, Significantly Boosting Domestic Supply and Export Capacity
The "mRNA Vaccine Industrial Production Platform," a collaboration between the South Korean governme...
US-based DataXight Launches protoXell, Extracting Mechanistic Insights from Large-Scale Perturbation Data to Accelerate Target Discovery and Drug Repositioning
DataXight, a biomedical data science company based in Mountain View, California, officially launched...
Canada's Cohere Acquires Germany's Reliant AI, Expanding Sovereign AI Footprint into Global Biopharma and Healthcare Sectors
Sovereign AI company Cohere of Canada announced on May 19 the official completion of its acquisition...
U.S.-based SandboxAQ Integrates Its Drug Discovery Models into Claude, Lowering the Barrier for Scientists
Wedoany News, May 18 - AI company SandboxAQ announced today the integration of its Large Quantitativ...
Germany's Romaco Debuts Maximus 400 Tablet Coater
Packaging machinery supplier Romaco will attend this year's Interpack exhibition, debuting the Maxim...
Insilico Medicine's Inhaled Solution Receives Clinical Trial Approval from China's CDE
Insilico Medicine recently announced that its drug candidate, Rentosertib Inhalation Solution, has r...
Samsung Bioepis Partners with ATLATL to Accelerate Biotech Incubation in Asia-Pacific
Samsung Bioepis Co., Ltd. and ATLATL Innovation Center recently announced the signing of a Memorandu...
India's Sun Pharma to Acquire Organon for $11.75 Billion
India's Sun Pharmaceutical Industries Ltd. announced it will acquire U.S.-based Organon in an all-ca...
U.S. Serif Launches Modified DNA Therapy with $50M Funding from Flagship Pioneering
U.S. startup Serif Biomedicines has recently emerged from stealth mode, introducing a novel therapeu...
Samsung Bioepis and ATLATL Collaborate to Accelerate Early-Stage Biotech Innovation in Asia-Pacific
Samsung Bioepis Co., Ltd. and ATLATL Innovation Centre, a global life science R&D innovation platfor...
Clinical Trial Pharmacy Software Drives Digital Transformation in Drug Development
The pharmaceutical and biotechnology industry is undergoing a major transformation in clinical trial...
Solengepras improves non-motor symptoms in Parkinson's disease
Solengepras has shown early potential in treating Parkinson's disease (PD), particularly targeting o...
IMG Pharma Acquires Japan's Matsumoto Pharmaceutical to Strengthen Integrated Healthcare Platform
IMG Pharma Co., Ltd. (IMG Pharma), based in Tokyo, Japan, announced that it has reached a definitive...
Xcovery Partners with EVERSANA to Expand Launch of ALK-Positive Lung Cancer Drug
Xcovery Holdings has entered into a collaboration agreement with commercialization services provider...
BD and Suttons Creek Partner to Advance Combination Product Development
Becton, Dickinson and Company (BD) and Suttons Creek, a BlueRidge Life Sciences company, have announ...
IDEAYA Biosciences Initiates Clinical Trial for New Drug to Address Solid Tumors and Cancer Drug Resistance
IDEAYA Biosciences, Inc., a precision medicine oncology company in the United States, announced that...
World's First! China's Radiomedicine's Nuclear Drug 99mTc-3PRGD2 Broad-Spectrum Tumor Imaging Agent Approved for Market Launch
On April 2, 2026, the China National Medical Products Administration approved the market launch of T...
U.S. Azurity Pharmaceuticals Launches New Oral Solution for Treating Attention Deficit Hyperactivity Disorder
Azurity Pharmaceuticals, Inc., a company dedicated to providing innovative pharmaceutical solutions ...
GEA and Hovione Collaborate to Launch Solution Accelerating Smart Tablet Manufacturing Development
German company GEA and Portuguese firm Hovione have joined forces to launch the SimpleCT solution, a...
$400 Million to Buy a "Pharmaceutical Brain": Anthropic Makes Its First Acquisition of AI Biotech Company Coefficient Bio
Claude's parent company has started buying "pharmaceutical brains." Anthropic has acquired AI biotec...